2Towner K J. Acinetobacter: An old friend, but a new enemy[J]. The Journal of Hospital Infection, 2009, 73 (4) : 355-363.
3Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii [J]. Nature Reviez~s Microbiology, 2007, 5(12) :939-951.
4Visca P, Seifert H, Towner K J. Acinetohacter infec tion--An emerging threat to human health[J]. IUB- MB Life, 2011,63(12) :1048q054.
5Zhanel G G,Wiebe R,Dilay L,et al. Comparative re- view of the carbapenems[J]. Drugs, 2007, 67 (7): 1027-1052.
6Lee K, Lim Y S, Yong D, et al. Evaluation of the Hodge test and the imipenem-EDTA double-disk syn- ergy test for differentiating metallo beta-lactamase- producing isolates of Pseudomonas spp. and Acineto- bacter spp. [J]. Journal of Clinical Microbiology, 2003,41(10) ..4623-4629.
7Poirel L, Walsh T R, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes~J]. Di agnostic Microbiology and Infectious Disease, 2011, 70(1) :119-123.
8CLSI. Performance standards for antimicrobial sus ceptibility testing~Twenty-third informational supple ment. CLSI document M100-$23 FS2. Wayne, PA CLSI,2013.
9Lemos E V,de la Hoz F P,Einarson R,et al. Carbap- enem resistance and mortality in patients with Acine- tobacter baumannii infection: Systematic review and meta-analysis~-J~. Clinical Microbiology and Infec- tion, 2014,20(5) .. 416-423.
10Wang S J, Chiu S H, Lin Y C, et al. Carbapenem re- sistant Enterobacteriaceae carrying New Delhi metal= lo-~-lactamasegene (NDM-1) in TaiwanCJ~. Diagnos- tic Microbiology and Infectious Disease, 2013, 76(2) ..248-249.
